Glutathione helps slow down aging by fighting harmful free radicals
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Glutathione supplementation serves as a valuable tool in replenishing glutathione levels, offering protection against these risks
Ballini A, Capodiferro S, Toia M, Cantore S, Favia G, De Frenza G
Indole-3-carbinol forms diindolylmethane in the stomach, activates the aryl hydrocarbon receptor, shifts estrogen metabolism toward 2-hydroxylation, and induces cytochrome P450 1A1
Glynn, C., Zakowski, M
